Sun Pharmaceutical Industries Ltd. closed 11.02% short of its 52-week high of 1,960.20 rupees, which the company reached on ...

Welcome to the Sun Pharma Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock. Stay ahead of the market with our in-depth coverage of Sun Pharma, including ...

Art Garfunkel discusses his experience living with psoriasis as part of Sun Pharma’s I LUV YA for The Long Haul campaign.

Sun Pharmaceutical Industries Ltd. closed 10.67% short of its 52-week high of 1,960.20 rupees, which the company achieved on September 30th.

Dr. Kiran Mahasuar, Asst Professor at IMT Ghaziabad, writes why branded generics may still dominate volumes, but the real ...

The pharma sector is likely to maintain steady earnings. Most brokerages flag US business recovery as the key swing factor ...

Benchmark NSE Nifty50 index ended up 273.9 points at 24125.55, while the BSE Sensex stood up 855.3 points at 79408.5. Among ...

Sun Pharma declined 0.93 per cent to Rs 1,689.35. About10 per cent of the Sun Pharma's US specialty revenues is formulated in ...

The stock market is showing signs of strength again, delighting investors. Analysts have selected 10 amazing stocks for ...

US President Donald Trump has stated that the country is set to announce “major tariffs” on pharmaceutical imports very soon.

Several states are reporting cases of measles, a highly contagious viral disease. Both children and adults can get measles.

Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune system differences ...